Cargando…
Long Non-Coding RNA NNT-AS1 Contributes to Cisplatin Resistance via miR-1236-3p/ATG7 Axis in Lung Cancer Cells
PURPOSE: Lung cancer is one of the most prevailing human cancers worldwide. Emerging evidence implies that long non-coding RNA nicotinamide nucleotide transhydrogenase-antisense RNA1 (NNT-AS1) is implicated in the tumorigenesis of lung cancer. Herein, we aimed to expose the impact of NNT-AS1 on the...
Autores principales: | Wang, Haifeng, Guo, Min, Ding, Dongxiao, Yang, Feng, Chen, Zhongjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198444/ https://www.ncbi.nlm.nih.gov/pubmed/32431515 http://dx.doi.org/10.2147/OTT.S237576 |
Ejemplares similares
-
LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis
por: Liu, Yanjie, et al.
Publicado: (2020) -
NNT-AS1 modulates prostate cancer cell proliferation, apoptosis and migration through miR-496/DDIT4 axis
por: Yao, Changlei, et al.
Publicado: (2020) -
Long noncoding RNA NNT-AS1 promotes hepatocellular carcinoma progression and metastasis through miR-363/CDK6 axis
por: Lu, Ye-Bin, et al.
Publicado: (2017) -
LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis
por: Ma, Jing, et al.
Publicado: (2020) -
Long non-coding RNA NNT-AS1 functions as an oncogenic gene through modulating miR-485/BCL9 in cholangiocarcinoma
por: Huang, Lining, et al.
Publicado: (2019)